Biotie Therapies, Inc.(Acorda Therapeutics) Company

Biotie Therapies, Inc. offers therapeutic drug research and development services focusing on the treatment of neurological and psychiatric disorders. The company was formerly known as Synosia Therapeutics, Inc. and changed its name to Biotie Therapies, Inc. in February 2011. The company was incorporated in 2005 and is based in South San Francisco, California. Biotie Therapies, Inc. operates as a subsidiary of Acorda Therapeutics, Inc. Acorda has acquired Biotie Therapies. We invite you to explore to learn more about our company, including our continued development of BIotie clinical programs for tozadenant, SYN120 and BTT1023. Information regarding transfers of value made to healthcare professionals and healthcare organizations in connection with Biotie’s clinical development programs is also available.
Technology: Precision Medicine
Industry: Precision Medicine
Headquarters: South San Francisco
Founded Date: 1995
Employees Number: 11-50
Funding Status: M&A

Visit Website
Register and Claim Ownership